IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Noven Financial Group, Inc.

Q4 2017 Holdings

Filed 2018-02-14 | 33 holdings | $239.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$66.0K14,65027.6%
Powershares QQQ TrustUNIT SER 173935A104$23.2K148,7179.7%
Ishares(IWP)RUS MD CP GR ETF464287481$22.7K187,8959.5%
Ishares(IJS)S&P 600 SMCP VAL464287879$20.2K131,2418.4%
Ishares(IJT)S&P 600 SMCP GRW464287887$19.7K115,5768.2%
Wisdomtree(DON)MIDCP 400 GRTH97717W505$19.6K556,4488.2%
Ishares(HDV)CORE HIGH DV ETF46429B663$18.9K210,0417.9%
Powershares Global ETF TRAGG PFD PORT73936T565$8.0K540,6563.4%
Schwab Strategic TR(SCHD)US Dividend EQ808524797$5.7K112,0462.4%
Vangaurd Index Fund(VUG)GROWTH ETF922908736$5.7K40,5212.4%
Ishares(PFF)US PFD STK ETF464288687$3.9K103,2381.6%
Vanguard Index Fund(VBK)SML CP GRW ETF922908595$3.8K23,5161.6%
Ishares Gold Trust(IAUUSD)ISHARES464285105$3.1K249,1161.3%
Ishares(DVY)Select Dividend ETF464287168$2.9K29,6171.2%
Ishares(IWF)RUS 1000 GRW ETF464287614$2.1K15,8490.9%
Ishares(IVW)S&P 500 GROWTH464287309$2.1K13,6070.9%
Berkshire Hathaway Inc de(BRK/B)CL B NEW084670702$1.9K9,5050.8%
Vangaurd Index FDS(VBR)SM CP VAL ETF922908611$1.8K13,7880.8%
Vangaurd Index Fund(VTI)TOTAL STK MKT922908769$1.6K11,6080.7%
Powershares ETF TrustFINL PFD PTFL73935X229$1.1K57,8370.5%
Apple Inc(AAPL)COM037833100$8124,7990.3%
Ampio Pharmaceuticals IncCOM03209T109$643158,0590.3%
W P Carey Inc(WPC)COM92936U109$6078,8150.3%
Spdr Series Trust(SLYG)S&P 600 SMCP GRW78464A201$5962,6220.2%
Facebook Inc(META)CL A30303M102$5833,3050.2%
Ishares Silver Trust(SLV)ISHARES46428Q109$56935,6050.2%
Ishares TR(MTUM)MSCI USAMOMFCT46432F396$3473,3690.1%
Vangaurd Sector(VHT)HEALTH CARE ETF92204A504$2891,8760.1%
Best BUY Inc(BBY)COM086516101$2293,3440.1%
Etfs Silver TRSILVER SHS26922X107$21513,0370.1%
Immunomedics Inc(IMMU)COM452907108$19412,0000.1%
Etfis SER TR IINFRAC ACT MLP26923G103$12214,1920.1%
Pluristem Therapeutics IncCOM72940R102$1712,0000.0%